Ellsworth Advisors, LLC Lantheus Holdings, Inc. Transaction History

Ellsworth Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 24, 2023	SELL	$82.41 - $99.65 $191,356 - $231,387	-2,322 Reduced 17.69%	10,807 $906,000
Q1 2023 Apr 12, 2023	SELL	$47.76 - $82.86 $5,826 - $10,108	-122 Reduced 0.92%	13,129 $1.08 Million
Q4 2022 Jan 19, 2023	SELL	$48.76 - $77.67 $32,425 - $51,650	-665 Reduced 4.78%	13,251 $0
Q3 2022 Oct 20, 2022	SELL	$61.42 - $86.29 $62,709 - $88,102	-1,021 Reduced 6.84%	13,916 $979,000
Q2 2022 Jul 25, 2022	SELL	$55.54 - $72.65 $25,992 - $34,000	-468 Reduced 3.04%	14,937 $986,000
Q1 2022 Apr 21, 2022	BUY	$24.28 - $56.64 $374,033 - $872,539	15,405 New	15,405 $982,000

538

68.4M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.7B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Ellsworth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ellsworth Advisors, LLC with notifications on news.